Age- and stage-dependent accumulation of advanced glycation end products in intracellular deposits in normal and Alzheimer's disease brains

Hans Joachim Lüth, Vera Ogunlade, Björn Kuhla, Rosemarie Kientsch-Engel, Peter Stahl̀, Julie Webster, Thomas Arendt, Gerald Münch

Research output: Contribution to journalArticlepeer-review

186 Citations (Scopus)

Abstract

In this immunohistochemical study, the age- and stage-dependent accumulation of advanced glycation end-products (AGEs) in Alzheimer's disease (AD) and their relation to the formation of neurofibrillary tangles and neuronal cell death was investigated. For this purpose, the distribution of AGEs in neurons and glia was analyzed in the auditory association area of superior temporal gyrus (Brodmann area 22) of young and old non-demented controls and compared with early- and late-stage AD. A possible co-localization of AGEs with typical hallmarks of AD, such as hyperphosphorylated tau (as a marker for disturbed kinase/phosphatase activity), nNOS (as a marker for nitroxidative stress) and caspase-3 (as a marker of apoptotic cell death), was also investigated. Our results show that the percentage of AGE-positive neurons (and astroglia) increase both with age and, in AD patients, with the progression of the disease (Braak stages). Interestingly, nearly all if those neurons which show diffuse cytosolic AGE immunoreactivity also contain hyperphosphoryated tau, suggesting a link between AGE accumulation and the formation of early neurofibrillary tangles. Many, but not all, neurons show a co-localization of AGEs with other markers of neurodegeneration, such as nNOS and caspase-3.

Original languageEnglish
Pages (from-to)211-220
Number of pages10
JournalCerebral Cortex
Volume15
Issue number2
DOIs
Publication statusPublished - Feb 2005
Externally publishedYes

Keywords

  • Advanced glycation endproducts
  • Alzheimer's disease
  • Braak stages
  • Neurofibrillary tangles
  • Nitric oxide

Fingerprint

Dive into the research topics of 'Age- and stage-dependent accumulation of advanced glycation end products in intracellular deposits in normal and Alzheimer's disease brains'. Together they form a unique fingerprint.

Cite this